Melatonin or Vitamin D for heart protection during chemo
Part of Cancer, Heart & circulation clinical trials.
This trial tests if taking melatonin or vitamin D can help protect the heart in women receiving doxorubicin chemotherapy for breast cancer. It aims to find a safe way to reduce heart damage from treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women aged 18 to 65 years
- Diagnosed with breast cancer that is HER2-negative
- Scheduled to start doxorubicin chemotherapy
- Good overall health (able to do daily activities)
- Normal heart function (ejection fraction ≥50%)
- Normal kidney and liver function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a daily pill called dapagliflozin can help protect the heart from damage caused by doxorubicin chemotherapy in people being treated for early-stage breast cancer. If you are starting doxorubicin and have a healthy heart, this might lower your risk of heart problems later.
This trial tests if vitamin D supplements can help breast cancer patients who have low vitamin D levels and are starting taxane-based chemotherapy. It aims to see if vitamin D can reduce side effects or improve outcomes.
This trial tests if telmisartan, a blood pressure medicine, can protect the heart from damage caused by the chemotherapy drug doxorubicin in women with breast cancer.
This trial tests whether adding melatonin to standard chemotherapy before surgery can help treat breast cancer. The goal is to see if melatonin improves how well the chemotherapy works.
This trial checks how well the heart handles anthracycline chemotherapy in breast cancer patients. It helps doctors find early signs of heart side effects so they can keep you safe during treatment.
This trial tests if a medicine called pentoxifylline can help prevent heart damage caused by doxorubicin, a common chemotherapy drug for breast cancer. If you are starting doxorubicin for the first time, this study may offer added heart protection.
Hear when a new Melatonin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.